NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









TriFlo Cardiovascular Inc.

TriFlo Cardiovascular Inc.

Private
Newport Beach, CaliforniaHealthcare & Life Scienceshttps://triflocv.com/

Last Round

Series B

Jan 23, 2024

Total Funding Raised

$15.47M

Company Overview

TriFlo Cardiovascular Inc. is a biotechnology company that develops a transcatheter system to treat tricuspid valve regurgitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Clinical Trials

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

tricuspid regurgitationtranscatheter therapymedical devicetricuspid valve repairstructural heartcardiac implantTRinterventional cardiologyTTVRtranscatheter tricuspid repairminimally invasive surgeryheart valve therapyMedTechtransfemoral deliveryclinical stage

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

TriFlo Cardiovascular Inc. Comparables

Compare TriFlo Cardiovascular Inc. with similar companies based on industry and business-model similarity.

TriFlo Cardiovascular Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Coramaze Technologies
89%
CroíValve
89%
StarTric
88%

TriFlo Cardiovascular Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BJan 23, 2024
Series AJun 16, 2022
VC RoundJul 22, 2020
AngelJul 2, 2019
SeedNov 22, 2017

Key People

Founding team and executive leadership

Kunal Sarkar

Chief Medical Officer, Member Board Of Directors

Executive Team

TriFlo Cardiovascular Inc. Investors

Notable investors and investment history

TriFlo Cardiovascular Inc. investors
InvestorRounds
Altano CapitalSeries A
Ceros Capital MarketsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jan 20, 2026

    Monthly visitors increased 70% MoM.

  • May 1, 2025

    Monthly visitors grew 103% MoM, reaching 1.4K.

TriFlo Cardiovascular Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

TriFlo Cardiovascular Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about TriFlo Cardiovascular Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersNewport Beach, California
Employee Range6
Year Founded2017
Last FundingJan 23, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.